Cargando…

Insulin Clearance in Obesity and Type 2 Diabetes

Plasma insulin clearance is an important determinant of plasma insulin concentration. In this review, we provide an overview of the factors that regulate insulin removal from plasma and discuss the interrelationships among plasma insulin clearance, excess adiposity, insulin sensitivity, and type 2 d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koh, Han-Chow E., Cao, Chao, Mittendorfer, Bettina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776220/ https://www.ncbi.nlm.nih.gov/pubmed/35054781 http://dx.doi.org/10.3390/ijms23020596

Ejemplares similares

β Cell function and plasma insulin clearance in people with obesity and different glycemic status
por: Mittendorfer, Bettina, et al.
Publicado: (2022)

Adipose tissue lipolysis, plasma fatty acids, and glucose homeostasis in people with obesity: New pieces that help solve the puzzle
por: Koh, Han-Chow E., et al.
Publicado: (2021)

Recombinant Human Leptin Treatment Does Not Improve Insulin Action in Obese Subjects With Type 2 Diabetes
por: Mittendorfer, Bettina, et al.
Publicado: (2011)

A Non-obese, Treatment-Naive Japanese Diabetic Patient With Elevated Insulin Clearance and Hyperglycemia Under Enhanced Insulin Sensitivity and Increased Insulin Secretion: Elevated Insulin Clearance as Type 2 Japanese Diabetes Mellitus (T2JDM)
por: Sugiyama, Seigo, et al.
Publicado: (2021)

Multiorgan Insulin Sensitivity in Lean and Obese Subjects
por: Conte, Caterina, et al.
Publicado: (2012)

The Physiology of Insulin Clearance
por: Bergman, Richard N., et al.
Publicado: (2022)

Hyperinsulinemia in Individuals with obesity: Role of Insulin Clearance
por: Kim, Mee Kyoung, et al.
Publicado: (2015)

Molecular Mechanism of Insulin Resistance in Obesity and Type 2 Diabetes
por: Choi, Kangduk, et al.
Publicado: (2010)

Insulin detemir for the treatment of obese patients with type 2 diabetes
por: Hollander, Priscilla A
Publicado: (2012)

Targeting Insulin-Degrading Enzyme in Insulin Clearance
por: Leissring, Malcolm A., et al.
Publicado: (2021)

Gut microbiota impairs insulin clearance in obese mice
por: Foley, Kevin P., et al.
Publicado: (2020)

The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus
por: Lewitt, Moira S., et al.
Publicado: (2014)

Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications
por: Wondmkun, Yohannes Tsegyie
Publicado: (2020)

Complement activation in obesity, insulin resistance, and type 2 diabetes mellitus
por: Shim, Kyumin, et al.
Publicado: (2020)

Insulin Resistance, Secretion and Clearance –Taming the Three Effector Encounter of Type 2 Diabetes
por: Bar-Tana, Jacob
Publicado: (2021)

Insulin Clearance and the Incidence of Type 2 Diabetes in Hispanics and African Americans: The IRAS Family Study
por: Lee, C. Christine, et al.
Publicado: (2013)

Dissecting the Relationship between Obesity and Hyperinsulinemia: Role of Insulin Secretion and Insulin Clearance
por: Kim, Mee Kyoung, et al.
Publicado: (2016)

Seafood intake and the development of obesity, insulin resistance and type 2 diabetes
por: Liaset, Bjørn, et al.
Publicado: (2019)

Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy
por: Fleischman, Amy, et al.
Publicado: (2009)

The involvement of aldosterone on vascular insulin resistance: implications in obesity and type 2 diabetes
por: Bruder-Nascimento, Thiago, et al.
Publicado: (2014)

Reduced insulin clearance is linked to subclinical atherosclerosis in individuals at risk for type 2 diabetes mellitus
por: Randrianarisoa, Elko, et al.
Publicado: (2020)

Non-nutritive Sweeteners and Their Associations with Obesity and Type 2 Diabetes
por: Walbolt, Jarrett, et al.
Publicado: (2020)

Response to Comment on Smith et al. Protein Ingestion Induces Muscle Insulin Resistance Independent of Leucine-Mediated mTOR Activation. Diabetes 2015;64:1555–1563
por: Smith, Gordon I., et al.
Publicado: (2015)

Obesity, insulin resistance, and the pathway to type 2 diabetes
por: Bergman, Richard N
Publicado: (2012)

Short-Term SGLT2 Inhibitor Administration Does Not Alter Systemic Insulin Clearance in Type 2 Diabetes
por: Sato, Motonori, et al.
Publicado: (2021)

Regulation of Insulin Clearance by Non-Esterified Fatty Acids
por: Najjar, Sonia M., et al.
Publicado: (2022)

Correlates of insulin clearance in apparently healthy non-obese Japanese men
por: Kaga, Hideyoshi, et al.
Publicado: (2017)

Insulin Clearance at the Pubertal Transition in Youth with Obesity and Steatosis Liver Disease
por: Franceschi, Roberto, et al.
Publicado: (2023)

Role of skeletal muscle lipids in the pathogenesis of insulin resistance of obesity and type 2 diabetes
por: Gilbert, Marc
Publicado: (2021)

Vancomycin Clearance in Obese Adults is not Predictive of Clearance in Obese Adolescents
por: Zhang, Tan, et al.
Publicado: (2023)

Erratum. Hypothesis: Role of Reduced Hepatic Insulin Clearance in the Pathogenesis of Type 2 Diabetes. Diabetes 2019;68:1709–1716
por: Bergman, Richard N., et al.
Publicado: (2019)

Sleeve Gastrectomy-Induced Weight Loss Increases Insulin Clearance in Obese Mice
por: Soares, Gabriela Moreira, et al.
Publicado: (2023)

Role of Insulin Clearance in Insulin Action and Metabolic Diseases
por: Ghadieh, Hilda E., et al.
Publicado: (2023)

Rewiring of Lipid Metabolism in Adipose Tissue Macrophages in Obesity: Impact on Insulin Resistance and Type 2 Diabetes
por: Dahik, Veronica D., et al.
Publicado: (2020)

Successful Withdrawal of Insulin Therapy After Post-Treatment Clearance of Hepatitis C Virus in a Man with Type 2 Diabetes
por: Davis, Timothy M. E., et al.
Publicado: (2017)

Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes
por: Dardano, Angela, et al.
Publicado: (2014)

Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance
por: Herman, Rok, et al.
Publicado: (2023)

Dietary Flavonoids and Insulin Signaling in Diabetes and Obesity
por: Martín, María Ángeles, et al.
Publicado: (2021)

Major Pathophysiology in Prediabetes and Type 2 Diabetes: Decreased Insulin in Lean and Insulin Resistance in Obese
por: Kabadi, Udaya M.
Publicado: (2017)

Bile acid TUDCA improves insulin clearance by increasing the expression of insulin-degrading enzyme in the liver of obese mice
por: Vettorazzi, Jean Franciesco, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m5910muvrr7rn47mtrr7dfj3eu